monoclonal antibody

Feds clamping down on COVID-19 antibody treatments in states like Tenn.

President Joe Biden’s administration is imposing new limits on COVID-19 antibody treatments in states like Tennessee where governors have relied on the drug instead of imposing stricter mitigation efforts, Politico reports.

Until now, the federal government has shipped the monoclonal antibody drugs on an as-needed basis, and seven Southern states — Texas, Florida, Mississippi, Tennessee, Georgia, Louisiana and Alabama — have accounted for 70% of the orders this month.

Under the new approach, the drugs would be allocated to states on a proportional basis rather than where outbreaks happen to be the worst. Critics say the current demand in states with high per-capita infection rates reflects a political resistance to vaccines and masks.

Tennessee Health Department spokeswoman Sarah Tanksley tells Politico the new scrutiny of state orders has resulted in delays getting the drugs to providers.